ATTO CIK: 2058707

Attovia Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium

Price analysis

Chart shows the share price.

Data table: Stock Price (EUR)
Point in timePrice
Sep 28, 202615.5 EUR
Sep 29, 202616 EUR
Sep 30, 202615.1 EUR
Oct 1, 202615.7 EUR
Oct 2, 202615.3 EUR
Oct 5, 202616.1 EUR
Oct 6, 202615.5 EUR
Oct 7, 202614.7 EUR
Oct 8, 202614.6 EUR
Oct 9, 202614.5 EUR
Oct 12, 202613 EUR
Oct 13, 202613.2 EUR
Oct 14, 202613.4 EUR
Oct 15, 202613.2 EUR
Oct 16, 202612.2 EUR
Oct 19, 202612.4 EUR
Oct 20, 202612.5 EUR
Oct 21, 202612.6 EUR
Oct 22, 202612.9 EUR
Oct 23, 202612.4 EUR
Oct 26, 202612.4 EUR

Price as of: Oct 26, 2026 closing price

Data source:Twelve Data

Key metrics overview

Metrics score locked — part of Premium
Unlock metrics and scores View Premium
Valuation
Available with Premium/ 100
  • Price-to-Earnings Ratio No meaningful value available
  • Price-to-Sales Ratio Available with Premium
  • Price-to-Free-Cashflow Available with Premium
  • Growth-Adjusted P/E Available with Premium
Growth
Available with Premium/ 100
  • Revenue Growth No meaningful value available
  • Earnings Growth Available with Premium
  • Free Cash Flow Growth Available with Premium
  • Net Margin Change Available with Premium
  • Free Cash Flow Margin Change Available with Premium
  • Earnings-per-Share Growth Available with Premium
  • Growth Consistency Available with Premium
Profita­bility
Available with Premium/ 100
  • Return on Equity 56.68%
  • Return on Assets Available with Premium
  • Return on Invested Capital Available with Premium
  • Operating Profit Margin Available with Premium
  • Net Profit Margin Available with Premium
Stability
Available with Premium/ 100
  • Revenue Stability 55 / 100
  • Earnings Stability Available with Premium
  • Cashflow Stability Available with Premium
  • Crisis Performance Available with Premium
  • Price Fluctuations Available with Premium
  • Maximum Price Loss Available with Premium
Debt
Available with Premium/ 100
  • Debt-to-Equity Ratio Available with Premium
  • Debt-to-Assets Available with Premium
  • Net Debt / EBITDA Available with Premium
  • Interest Coverage Ratio Available with Premium
Cashflow
Available with Premium/ 100
  • Operating Cashflow Available with Premium
  • Free Cashflow Available with Premium
  • Free Cashflow Margin Available with Premium
Dividends
Available with Premium/ 100
  • Dividend Yield Available with Premium
  • Dividend Payout Ratio Available with Premium
  • Dividend Growth Available with Premium
  • Years without a cut Available with Premium

Every metric explained simply

Market comparison

Ranking unavailable

No ranking can be calculated for this company at the moment.

Revenue and Profit Performance

Data table: Revenue and Profit Performance (B USD)
Point in timeRevenueProfit
FY25 (Dec 31, 2025)0 B USD−0.1 B USD
FY24 (Dec 31, 2024)0 B USD0 B USD
FY21 (Dec 31, 2021)1.5 B USD−0.1 B USD
FY20 (Dec 31, 2020)1.4 B USD−0.1 B USD
FY19 (Dec 31, 2019)1.7 B USD−0.1 B USD

All amounts in billions USD Data source:Twelve Data

More Companies

The largest other companies in Biotech, part of the Healthcare sector.

All stocks in Biotech